162 related articles for article (PubMed ID: 35493500)
1. Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases.
Martínez-Chinchilla C; Vazquez-Montero L; Palazón-Carrión N; Fernández-Román IM; López-Barba J; de la Cruz-Merino L; Rodríguez-Baño J; Palacios-Baena ZR
Front Immunol; 2022; 13():860891. PubMed ID: 35493500
[TBL] [Abstract][Full Text] [Related]
2. Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
Mikulska M; Sepulcri C; Dentone C; Magne F; Balletto E; Baldi F; Labate L; Russo C; Mirabella M; Magnasco L; Di Grazia C; Ghiggi C; Raiola AM; Giacobbe DR; Vena A; Beltramini S; Bruzzone B; Lemoli RM; Angelucci E; Bassetti M
Clin Infect Dis; 2023 Jul; 77(2):280-286. PubMed ID: 36976301
[TBL] [Abstract][Full Text] [Related]
3. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: Case reports.
Deveci B; Saba R
Medicine (Baltimore); 2021 Dec; 100(52):e28470. PubMed ID: 34967391
[TBL] [Abstract][Full Text] [Related]
4. Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity.
Morishita M; Suzuki M; Matsunaga A; Ishizhima K; Yamamoto T; Kuroda Y; Kanno T; Tsujimoto Y; Ishida A; Hashimoto M; Ishii S; Takasaki J; Naka G; Iikura M; Izumi S; Suzuki T; Maeda K; Ishizaka Y; Hojo M; Sugiyama H
J Infect Chemother; 2022 Jul; 28(7):971-974. PubMed ID: 35184976
[TBL] [Abstract][Full Text] [Related]
5. Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab.
Van der Moeren N; Selhorst P; Ha M; Heireman L; Van Gaal PJ; Breems D; Meysman P; Laukens K; Verstrepen W; Van Gasse N; Ogunjimi B; Arien KK; Naesens R
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458482
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
Riise J; Meyer S; Blaas I; Chopra A; Tran TT; Delic-Sarac M; Hestdalen ML; Brodin E; Rustad EH; Dai KZ; Vaage JT; Nissen-Meyer LSH; Sund F; Wader KF; Bjornevik AT; Meyer PA; Nygaard GO; König M; Smeland S; Lund-Johansen F; Olweus J; Kolstad A
Br J Haematol; 2022 Jun; 197(6):697-708. PubMed ID: 35254660
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma.
Colombo D; Gatti A; Alabardi P; Bompane D; Bonardi G; Mumoli N; Faggioli P; Clerici P; Brando B; Mazzone A
J Hematol; 2022 Apr; 11(2):77-80. PubMed ID: 35573753
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies.
Calderón-Parra J; Múñez-Rubio E; Fernández-Cruz A; García-Sánchez MC; Maderuelo-González E; López-Dosil M; Calvo-Salvador M; Baños-Pérez I; Valle-Falcones M; Ramos-Martínez A
Clin Infect Dis; 2022 May; 74(10):1786-1794. PubMed ID: 34383032
[TBL] [Abstract][Full Text] [Related]
9. Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.
Ertesvåg NU; Sakkestad ST; Zhou F; Hoff I; Kristiansen T; Jonassen TM; Follesø E; Brokstad KA; Dyrhovden R; Mohn KG
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016378
[No Abstract] [Full Text] [Related]
10. COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.
Furlan A; Forner G; Cipriani L; Vian E; Rigoli R; Gherlinzoni F; Scotton P
Front Immunol; 2021; 12():763412. PubMed ID: 34804051
[TBL] [Abstract][Full Text] [Related]
11. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL; Ganapathiraju PV; Kurtz CP; Wainscoat B
Am J Case Rep; 2020 Oct; 21():e927812. PubMed ID: 33009361
[TBL] [Abstract][Full Text] [Related]
12. Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma.
Da Silva L; Klopfenstein T; Gendrin V; Clouet J; Toko L; Richier Q; Leriche T; Nicolas R; Queijo A; Sreiri N; Lacombe K; Zayet S
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005897
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review.
Rodriguez-Pla A; Vikram HR; Khalid V; Wesselius LJ
Rheumatol Int; 2021 Aug; 41(8):1509-1514. PubMed ID: 34091704
[TBL] [Abstract][Full Text] [Related]
14. Prolonged
Papanikolopoulou A; Thimis V; Antonogiannaki E; Rapti V; Tsiakos K; Krallis G; Ntouraki S; Kokkotis G; Panagiotou E; Sakka V; Kakalou E; Nitsotolis T; Poulakou G; Syrigos KN
In Vivo; 2023; 37(1):461-467. PubMed ID: 36593037
[TBL] [Abstract][Full Text] [Related]
15. Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.
D'Abramo A; Vita S; Maffongelli G; Beccacece A; Agrati C; Cimini E; Colavita F; Giancola ML; Cavasio A; Nicastri E;
Front Immunol; 2022; 13():911339. PubMed ID: 35711444
[TBL] [Abstract][Full Text] [Related]
16. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
[TBL] [Abstract][Full Text] [Related]
17. Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-CD20 antibodies.
Sakamaki I; Negoro E; Iwasaki H; Yamauchi T
J Infect Chemother; 2024 Feb; 30(2):147-149. PubMed ID: 37690521
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Curtò D; Tomatis F; Gastoldi S; Galbusera M; Noris M; Raimondi F; Lorini FL; Falanga A; Marchetti M; Remuzzi G; Ruggenenti P
Front Immunol; 2021; 12():711915. PubMed ID: 34276706
[TBL] [Abstract][Full Text] [Related]
19. Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies.
Shimizu A; Shirai I; Ogawa K; Miura A; Haruhara K; Oshiro K; Hamaguchi A; Yokote S; Okabe M; Ueda H; Tsuboi N; Ikeda M; Yokoo T
Intern Med; 2022 Dec; 61(24):3703-3708. PubMed ID: 36171121
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
